Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1995 | 12-1994 | 12-1993 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 300 | 70 | N/A |
| Marketable Securities | 1,050 | 5,630 | N/A |
| Receivables | 2 | 180 | N/A |
| Inventories | 60 | 50 | N/A |
| Other current assets | 8 | 120 | 0 |
| TOTAL | $1,420 | $6,050 | $N/A |
| Non-Current Assets | |||
| Other Non-Current Assets | 230 | 260 | 0 |
| TOTAL | $230 | $260 | $N/A |
| Total Assets | $3,570 | $8,150 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 240 | 230 | 0 |
| Accrued Expenses | 80 | 40 | N/A |
| TOTAL | $370 | $4,960 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 300 | N/A | N/A |
| TOTAL | $300 | $N/A | $N/A |
| Total Liabilities | $670 | $4,960 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 60 | 20 | N/A |
| Retained earnings | -4,220 | -3,090 | N/A |
| TOTAL | $2,900 | $3,180 | $N/A |
| Total Liabilities And Equity | $3,570 | $8,140 | $0 |